Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: TARO PHARMACEUTICALS USA INC

Planned inspection · Health discipline

On , OSHA opened a planned health inspection of TARO PHARMACEUTICALS USA INC in 1710 CHATTAHOOCHEE RUN DR, SUWANEE, GA 30024 (NAICS 424210). OSHA activity number 346935703.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Taro Pharmaceuticals USA INC — free Get an email when a new federal OSHA severe-injury report for Taro Pharmaceuticals USA INC is published. One employer, no account, unsubscribe in one click.
Site address
1710 CHATTAHOOCHEE RUN DR
City
SUWANEE
State
GA
ZIP
30024
Mailing
1710 CHATTAHOOCHEE RUN DR, SUWANEE, GA 30024
Inspection type
Planned (H)
Scope
No inspection (D)
Discipline
Health
Advance notice
No
Union status
B
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
424210
Employees
10
Ownership type
A

No citations on file for this inspection — so there is no finding of any violation on this record. An inspection can be open and still ongoing, or closed with no violations at all; OSHA's citation feed is also backfilled in rolling windows, so citation rows for a very recent inspection may not have been ingested yet.

View Taro Pharmaceuticals USA INC's full OSHA safety record →

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 346935703.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.